Meniscus Regeneration After Meniscectomy and Its Clinical Significance
1 other identifier
observational
50
1 country
1
Brief Summary
Meniscus injury is common in sports-active population, and partial or total meniscectomy is standard surgery for meniscal tear. Meniscus plays an important role in load transferring, shock absorbing, knee joint stabilizing and chondral protection. Plenty of studies indicate that meniscus-deficiency increases the risk of OA and cause long-term poor outcomes. Spontaneous human meniscus regeneration is rarely reported and whether regenerated meniscus is chondral-protective and can prevent OA progression remain unknown. During our clinical practice, we have encountered many cases with complete meniscal regeneration under arthroscopy. In this study, we will include all the patients who receiving meniscectomy and ACL reconstruction and knee arthroscopy 2 years after primary surgery. Patients demographic characters will be reviewed. The resected meniscus in the primary surgery and biopsied regenerated meniscus will be analyzed by histological and immunohistochemical method and their ultrastructure will be observed by electron microscope. Patients will be followed at 2-, 5- and 10-year after the primary surgery and the cartilage degeneration and OA progression will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 16, 2021
CompletedFirst Posted
Study publicly available on registry
July 13, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJuly 13, 2021
July 1, 2021
2.3 years
June 16, 2021
July 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
meniscus regeneration
the resected meniscus regeneration is found under the arthroscopy.
2 year
Study Arms (2)
Meniscus regeneration
Reconstruction of the anterior cruciate ligament, total or partial meniscus resection was performed in our hospital, and two years after the operation, the meniscus regeneration was found under secondary arthroscopy.
Meniscus without regeneration
Anterior cruciate ligament reconstruction, total or partial meniscus resection was performed in our hospital, and two years after the operation, no meniscus regeneration was found under secondary arthroscopy.
Interventions
Eligibility Criteria
all the patients receving meniscectomy
You may qualify if:
- Patients intending to undergo single-knee ACL reconstruction at our Institute of Sports Medicine.
- The age of 18 \~ 50 years old at the time of operation.
- Both men and women.
- BMI \< 24.
- Complete or partial meniscectomy was performed at the same time as ACL reconstruction.
- Patients willing to undergo a second arthroscopic exploration 2 years postoperatively and to take the portal screws used to fix the ligaments during the initial surgery.
- Patients with preserved meniscus video during ACL reconstruction.
- The degree of knee osteoarthritis (KOA) at the time of operation was \< Ⅲ of Kellgren Laurence level.
You may not qualify if:
- Patients with severe knee cartilage injury.
- Patients with KOA≥KLⅢ at the time of operation.
- The patients cannot be followed up.
- Patients who refused the second arthroscopy and the removal of the internal fixation portal screw at the time of surgery.
- Patients with rheumatoid arthritis or other arthritis.
- Patients with other systemic diseases who take oral anti-inflammatory analgesics for years.
- Patients with multiple injections of drugs in the joint due to various reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sports Medicine, Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Biospecimen
resected meniscus and biopsy of regenerated meniscus
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zimu Mao, Dortor
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2021
First Posted
July 13, 2021
Study Start
June 1, 2020
Primary Completion
September 1, 2022
Study Completion
December 1, 2022
Last Updated
July 13, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share